All Stories

  1. Schistosomiasis‐Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition—2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives
  2. Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension
  3. Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force
  4. A Tale of Two Organs: The Liver–Lung Axis in Pulmonary Disease
  5. Chronic Dyspnea and Residual Pulmonary Vascular Sequelae After COVID‐19 Pulmonary Embolism: A Retrospective Analysis
  6. Oxygen pulse plateau as a qualitative marker for risk stratification in PAH
  7. Physiologic relevance of the transpulmonary metabolome in connective tissue disease–associated pulmonary vascular disease
  8. Immune Profile of Peripheral Blood Mononuclear Cells in Patients With Schistosoma-induced Pulmonary Hypertension
  9. Orthostatic hypotension in precapillary pulmonary hypertension: prevalence, clinical profile and hemodynamic mechanisms
  10. Morbidity and Mortality Associated With Pulmonary Arterial Hypertension in a Schistosomiasis‐Endemic Region of Brazil
  11. Clinical, Functional, and Hemodynamic Profile of Schistosomiasis-Associated Pulmonary Arterial Hypertension Patients in Brazil: Systematic Review and Meta-Analysis
  12. COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease
  13. Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance
  14. Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling
  15. COVID-19 and Parasitic Coinfection: A Hypothetical Link to Pulmonary Vascular Disease
  16. Prognostic relevance of Exercise Pulmonary Hypertension: Results of the multi-center PEX-NET Clinical Research Collaboration
  17. Infection and pulmonary vascular diseases consortium: United against a global health challenge
  18. The role of the exercise physiology laboratory in disease management: pulmonary arterial hypertension
  19. Cardiopulmonary exercise test 3 to 12 months after COVID-19 hospitalization
  20. Residual lung abnormalities after 12 months of COVID19 hospitalization: A brazilian multicenter study
  21. Dyspnea Investigation in Behçet’s Disease: The Role of Advanced Diagnostic Methods to Elucidate Dyspnea in Systemic Diseases
  22. The role of the pulmonary function laboratory to assist in disease management: pulmonary hypertension
  23. CD147 Plasma Levels in Hospitalised Patients with Covid-19 Pneumonia Predict Illness Severity and In-Hospital Mortality
  24. Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil
  25. Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
  26. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2
  27. Exercise intolerance in post-coronavirus disease 2019 survivors after hospitalisation
  28. Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
  29. Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology
  30. Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry
  31. Mechanisms of exercise intolerance after COVID-19: new perspectives beyond physical deconditioning
  32. Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  33. Sex-Related Differences in Dynamic Right Ventricular-Pulmonary Vascular Coupling in Heart Failure With Preserved Ejection Fraction
  34. Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension
  35. Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
  36. Schistosomiasis Pulmonary Arterial Hypertension
  37. Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension
  38. Systemic vascular distensibility relates to exercise capacity in connective tissue disease
  39. Dynamic right ventricular function response to incremental exercise in pulmonary hypertension
  40. Fick principle and exercise pulmonary hemodynamic determinants of the six‐minute walk distance in pulmonary hypertension
  41. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease
  42. Ventilatory and Gas Exchange Responses During Freewheeling Exercise in Pulmonary Arterial Hypertension
  43. Incremental step test in patients with pulmonary hypertension
  44. EXPRESS: Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
  45. Unexplained exertional intolerance associated with impaired systemic oxygen extraction
  46. Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension
  47. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension
  48. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction
  49. Tomographic features associated with excessive ventilatory responses during exercise in chronic pulmonary thromboembolic hypertension
  50. Clinical value of an abnormal increase of O2 pulse during early recovery from maximal exercise in patients with chronic thromboembolic pulmonary hypertension
  51. Dynamic right ventricular-pulmonary arterial (RV-PA) uncoupling during incremental exercise in HFpEF
  52. Right ventriculo–arterial uncoupling and impaired contractile reserve in obese patients with unexplained exercise intolerance
  53. Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis
  54. Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction
  55. Network Analysis to Risk Stratify Patients With Exercise IntoleranceNovelty and Significance
  56. Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?
  57. Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
  58. Short and long-term effects of pulmonary endarterectomy on ventilatory responses and exercise capacity of patients with chronic thromboembolic pulmonary hypertension
  59. Prognostic impact of exercise pulmonary hypertension
  60. Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
  61. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise
  62. Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure
  63. Hot topics from the Assemblies
  64. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center
  65. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise
  66. Clinical usefulness of end-tidal CO 2 profiles during incremental exercise in patients with chronic thromboembolic pulmonary hypertension
  67. Prognostic role of excessive exercise ventilation in non-operable patients with chronic thromboembolic pulmonary hypertension
  68. Pulmonary haemodynamics during recovery from maximum incremental cycling exercise
  69. PHYSIOLOGIC DYNAMIC RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTION DURING EXERCISE: CLINICAL IMPLICATIONS FOR EXERCISE ECHOCARDIOGRAPHY TO IDENTIFY ABNORMAL PULMONARY VASCULAR RESPONSE
  70. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival
  71. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics
  72. Central hemodynamic patterns during recovery from peak exercise
  73. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure
  74. A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis
  75. Erratum
  76. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension
  77. Destaques das diretrizes de doenças pulmonares intersticiais da Sociedade Brasileira de Pneumologia e Tisiologia